AngioDynamics ANGO Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
As of May 31, 2026, the carrying value of the financing arrangement was $5.8 million, of which $0.4 million was classified as "Other current liabilities" and $5.4 million was classified as "Other long-term liabilities" on the Consolidated Balance Sheets. As of May 31, 2025, the carrying value of the financing arrangement was $6.2 million, of which $0.4 million was classified as "Other current liabilities" and $5.8 million was classified as "Other long-term liabilities" on the Consolidated Balance Sheets. Interest expense associated with the financing arrangement was $0.4 million and $0.2 million, respectively, for the twelve months ending May 31, 2026 and 2025.
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's finance lease liabilities?
- AngioDynamics (ANGO) reported finance lease liabilities of $5.4M in Q1 2026.
- How has AngioDynamics's finance lease liabilities changed year-over-year?
- AngioDynamics's finance lease liabilities decreased by 6.9% year-over-year, from $5.8M to $5.4M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about AngioDynamics's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
